Literature DB >> 19762684

Insulin-like growth factor binding protein-3 mediates vascular repair by enhancing nitric oxide generation.

Jennifer L Kielczewski1, Yagna P R Jarajapu, Evan L McFarland, Jun Cai, Aqeela Afzal, Sergio Li Calzi, Kyung Hee Chang, Todd Lydic, Lynn C Shaw, Julia Busik, Jeffrey Hughes, Arturo J Cardounel, Kenneth Wilson, Timothy J Lyons, Michael E Boulton, Robert N Mames, Tailoi Chan-Ling, Maria B Grant.   

Abstract

RATIONALE: Insulin-like growth factor binding protein (IGFBP)-3 modulates vascular development by regulating endothelial progenitor cell (EPC) behavior, specifically stimulating EPC cell migration. This study was undertaken to investigate the mechanism of IGFBP-3 effects on EPC function and how IGFBP-3 mediates cytoprotection following vascular injury.
OBJECTIVE: To examine the mechanism of IGFBP-3-mediated repair following vascular injury. METHODS AND
RESULTS: We used 2 complementary vascular injury models: laser occlusion of retinal vessels in adult green fluorescent protein (GFP) chimeric mice and oxygen-induced retinopathy in mouse pups. Intravitreal injection of IGFBP-3-expressing plasmid into lasered GFP chimeric mice stimulated homing of EPCs, whereas reversing ischemia induced increases in macrophage infiltration. IGFBP-3 also reduced the retinal ceramide/sphingomyelin ratio that was increased following laser injury. In the OIR model, IGFBP-3 prevented cell death of resident vascular endothelial cells and EPCs, while simultaneously increasing astrocytic ensheathment of vessels. For EPCs to orchestrate repair, these cells must migrate into ischemic tissue. This migratory ability is mediated, in part, by endogenous NO generation. Thus, we asked whether the migratory effects of IGFBP-3 were attributable to stimulation of NO generation. IGFBP-3 increased endothelial NO synthase expression in human EPCs leading to NO generation. IGFBP-3 exposure also led to the redistribution of vasodilator-stimulated phosphoprotein, an NO regulated protein critical for cell migration. IGFBP-3-mediated NO generation required high-density lipoprotein receptor activation and stimulation of phosphatidylinositol 3-kinase/Akt pathway.
CONCLUSION: These studies support consideration of IGFBP-3 as a novel agent to restore the function of injured vasculature and restore NO generation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19762684      PMCID: PMC3635679          DOI: 10.1161/CIRCRESAHA.109.199059

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  36 in total

Review 1.  The role of the high-density lipoprotein receptor SR-BI in cholesterol metabolism.

Authors:  B Trigatti; A Rigotti; M Krieger
Journal:  Curr Opin Lipidol       Date:  2000-04       Impact factor: 4.776

Review 2.  Cellular actions of the insulin-like growth factor binding proteins.

Authors:  Sue M Firth; Robert C Baxter
Journal:  Endocr Rev       Date:  2002-12       Impact factor: 19.871

3.  High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase.

Authors:  I S Yuhanna; Y Zhu; B E Cox; L D Hahner; S Osborne-Lawrence; P Lu; Y L Marcel; R G Anderson; M E Mendelsohn; H H Hobbs; P W Shaul
Journal:  Nat Med       Date:  2001-07       Impact factor: 53.440

Review 4.  Molecular control of blood flow and angiogenesis: role of nitric oxide.

Authors:  W C Sessa
Journal:  J Thromb Haemost       Date:  2009-07       Impact factor: 5.824

5.  Interaction of sphingosine 1-phosphate with plasma components, including lipoproteins, regulates the lipid receptor-mediated actions.

Authors:  N Murata; K Sato; J Kon; H Tomura; M Yanagita; A Kuwabara; M Ui; F Okajima
Journal:  Biochem J       Date:  2000-12-15       Impact factor: 3.857

6.  Transferrin is an insulin-like growth factor-binding protein-3 binding protein.

Authors:  S A Weinzimer; T B Gibson; P F Collett-Solberg; A Khare; B Liu; P Cohen
Journal:  J Clin Endocrinol Metab       Date:  2001-04       Impact factor: 5.958

7.  Involvement of endothelial nitric oxide in sphingosine-1-phosphate-induced angiogenesis.

Authors:  Yoshiyuki Rikitake; Ken-ichi Hirata; Seinosuke Kawashima; Masanori Ozaki; Tomosaburo Takahashi; Wataru Ogawa; Nobutaka Inoue; Mitsuhiro Yokoyama
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-01       Impact factor: 8.311

8.  Sphingosine 1-phosphate may be a major component of plasma lipoproteins responsible for the cytoprotective actions in human umbilical vein endothelial cells.

Authors:  T Kimura; K Sato; A Kuwabara; H Tomura; M Ishiwara; I Kobayashi; M Ui; F Okajima
Journal:  J Biol Chem       Date:  2001-06-26       Impact factor: 5.157

9.  Tissue transglutaminase facilitates the polymerization of insulin-like growth factor-binding protein-1 (IGFBP-1) and leads to loss of IGFBP-1's ability to inhibit insulin-like growth factor-I-stimulated protein synthesis.

Authors:  K Sakai; W H Busby; J B Clarke; D R Clemmons
Journal:  J Biol Chem       Date:  2000-12-19       Impact factor: 5.157

10.  Bone marrow-derived stem cells target retinal astrocytes and can promote or inhibit retinal angiogenesis.

Authors:  Atsushi Otani; Karen Kinder; Karla Ewalt; Francella J Otero; Paul Schimmel; Martin Friedlander
Journal:  Nat Med       Date:  2002-07-29       Impact factor: 53.440

View more
  53 in total

1.  Tryptophanyl-tRNA Synthetase, a Novel Damage-Induced Cytokine, Significantly Increases the Therapeutic Effects of Endometrial Stem Cells.

Authors:  Se-Ra Park; Soo-Rim Kim; Jae-Been Im; Soyi Lim; In-Sun Hong
Journal:  Mol Ther       Date:  2020-06-19       Impact factor: 11.454

2.  Free insulin-like growth factor binding protein-3 (IGFBP-3) reduces retinal vascular permeability in association with a reduction of acid sphingomyelinase (ASMase).

Authors:  Jennifer L Kielczewski; Sergio Li Calzi; Lynn C Shaw; Jun Cai; Xiaoping Qi; Qing Ruan; Lin Wu; Li Liu; Ping Hu; Tailoi Chan-Ling; Robert N Mames; Sue Firth; Robert C Baxter; Patric Turowski; Julia V Busik; Michael E Boulton; Maria B Grant
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-10-21       Impact factor: 4.799

Review 3.  The mouse retina as an angiogenesis model.

Authors:  Andreas Stahl; Kip M Connor; Przemyslaw Sapieha; Jing Chen; Roberta J Dennison; Nathan M Krah; Molly R Seaward; Keirnan L Willett; Christopher M Aderman; Karen I Guerin; Jing Hua; Chatarina Löfqvist; Ann Hellström; Lois E H Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-06       Impact factor: 4.799

4.  Acute activation of eNOS by statins involves scavenger receptor-B1, G protein subunit Gi, phospholipase C and calcium influx.

Authors:  R Datar; W H Kaesemeyer; S Chandra; D J Fulton; R W Caldwell
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

5.  Growth factors/chemokines in diabetic vitreous and aqueous alter the function of bone marrow-derived progenitor (CD34⁺) cells in humans.

Authors:  Sankarathi Balaiya; Maria B Grant; Joshua Priluck; Kakarla V Chalam
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-08-26       Impact factor: 4.310

Review 6.  The promise of cell-based therapies for diabetic complications: challenges and solutions.

Authors:  Yagna P R Jarajapu; Maria B Grant
Journal:  Circ Res       Date:  2010-03-19       Impact factor: 17.367

7.  Blockade of NADPH oxidase restores vasoreparative function in diabetic CD34+ cells.

Authors:  Yagna P R Jarajapu; Sergio Caballero; Amrisha Verma; Takahiko Nakagawa; Margaret C Lo; Qiuhong Li; Maria B Grant
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-07-07       Impact factor: 4.799

8.  Nutrition, insulin-like growth factor-1 and retinopathy of prematurity.

Authors:  Anna-Lena Hård; Lois E Smith; Ann Hellström
Journal:  Semin Fetal Neonatal Med       Date:  2013-02-18       Impact factor: 3.926

9.  Transient inhibition of transforming growth factor-beta1 in human diabetic CD34+ cells enhances vascular reparative functions.

Authors:  Ashay D Bhatwadekar; E P Guerin; Yagna P R Jarajapu; Sergio Caballero; Carl Sheridan; David Kent; Laurence Kennedy; M Cecilia Lansang; Frank W Ruscetti; Carl J Pepine; Paul J Higgins; Stephen H Bartelmez; Maria B Grant
Journal:  Diabetes       Date:  2010-05-11       Impact factor: 9.461

10.  Inhibition of cytokine signaling in human retinal endothelial cells through downregulation of sphingomyelinases by docosahexaenoic acid.

Authors:  Madalina Opreanu; Todd A Lydic; Gavin E Reid; Kelly M McSorley; Walter J Esselman; Julia V Busik
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-01-13       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.